A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

NCT04614467 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

34

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Coronary Microvascular Dysfunction
Coronary Microvascular Disease
Microvascular Coronary Artery Disease

Interventions

BIOLOGICAL: CLBS16
BIOLOGICAL: Placebo

Sponsor

Lisata Therapeutics, Inc.